News

Investing in organizations like @gavialliance isn’t just the right thing to do, it’s the necessary thing to do.

As we ramp up to our National Advocacy Summit with @unitedtobeatmalaria, hear from Chloe Cooney, Director of U.S. Strategy for Gavi, to learn why.

Jan 29

Open

Investing in organizations like @gavialliance isn’t just the right thing to do, it’s the necessary thing to do.

As we ramp up to our National Advocacy Summit with @unitedtobeatmalaria, hear from Chloe Cooney, Director of U.S. Strategy for Gavi, to learn why.

According to a new @thelancetgroup study: during COVID-19, as real world evidence on vaccine safety and effectiveness grew, vaccine hesitancy dropped sharply.

65% of initially hesitant individuals ultimately chose vaccination.

Vaccine confidence isn’t build overnight—but new studies show it CAN be built. Trust grows when clear public health communications are made accessible.

Jan 28

Open

According to a new @thelancetgroup study: during COVID-19, as real world evidence on vaccine safety and effectiveness grew, vaccine hesitancy dropped sharply.

65% of initially hesitant individuals ultimately chose vaccination.

Vaccine confidence isn’t build overnight—but new studies show it CAN be built. Trust grows when clear public health communications are made accessible.

Entering 2026, the cholera crisis continues: 600K cases across 31 countries were reported last year alone.

Current vaccines help, but stockpiles are falling short, two doses are needed, and they’re not 100% effective in children under 5—our world’s most vulnerable.

Here’s the hope though: a novel single-dose vaccine has shown promising results in phase 1 trials. Unlike existing vaccines, all recipients in the trial developed antibodies that could kill the cholera bacterium entirely, suggesting stronger protection.

While we wait for further trials, remember: vaccines are just one tool. The real cure isn’t in a vial, but in access to safe water and sanitation. 💧

Jan 23

Open

Entering 2026, the cholera crisis continues: 600K cases across 31 countries were reported last year alone.

Current vaccines help, but stockpiles are falling short, two doses are needed, and they’re not 100% effective in children under 5—our world’s most vulnerable.

Here’s the hope though: a novel single-dose vaccine has shown promising results in phase 1 trials. Unlike existing vaccines, all recipients in the trial developed antibodies that could kill the cholera bacterium entirely, suggesting stronger protection.

While we wait for further trials, remember: vaccines are just one tool. The real cure isn’t in a vial, but in access to safe water and sanitation. 💧

Last year, disillusionment with vaccines, medical research, and even physicians hit an all-time high in the U.S.—and such a trend is far more damaging than you may think.

Learn more from Dr. Permar of @wcmpediatrics about why we need to change the conversation.

Jan 22

Open

Last year, disillusionment with vaccines, medical research, and even physicians hit an all-time high in the U.S.—and such a trend is far more damaging than you may think.

Learn more from Dr. Permar of @wcmpediatrics about why we need to change the conversation.

@Zipline is revolutionizing health in the world`s most remote regions, delivering millions of critical vaccines, medications, antivenoms, and blood units to rural facilities.

Their latest endeavor: a fleet of drones funded transforming the health landscape in rural Ghana. Drones have delivered 8.4 million medical products in Ghana from 2019 to 2025—drops credited with saving nearly 10,000 lives.

We have the vaccines. And now, we have increasingly innovative ways to distribute them.

Jan 21

Open

@Zipline is revolutionizing health in the world's most remote regions, delivering millions of critical vaccines, medications, antivenoms, and blood units to rural facilities.

Their latest endeavor: a fleet of drones funded transforming the health landscape in rural Ghana. Drones have delivered 8.4 million medical products in Ghana from 2019 to 2025—drops credited with saving nearly 10,000 lives.

We have the vaccines. And now, we have increasingly innovative ways to distribute them.

So, what is advocacy? According to Dr. Sallie Permar, Chair of Pediatrics at @wcmpediatrics, it’s simpler than you think.

Keep watching to learn more.

Jan 16

Open

So, what is advocacy? According to Dr. Sallie Permar, Chair of Pediatrics at @wcmpediatrics, it’s simpler than you think.

Keep watching to learn more.

Cervical cancer continues to be a major threat to women around the world—but it’s also one of the only cancers preventable by vaccine.

HPV vaccines have been proven to reduce cervical cancer by 90%. But in countries where social taboos hang overhead, ensuring girls receive these lifesaving vaccines is a monumental task.

This #CervicalCancer Awareness Month, we must recommit to using the tools in our toolbox that could save hundreds of thousands of lives lost to cervical cancer each year.

Jan 14

Open

Cervical cancer continues to be a major threat to women around the world—but it’s also one of the only cancers preventable by vaccine.

HPV vaccines have been proven to reduce cervical cancer by 90%. But in countries where social taboos hang overhead, ensuring girls receive these lifesaving vaccines is a monumental task.

This #CervicalCancer Awareness Month, we must recommit to using the tools in our toolbox that could save hundreds of thousands of lives lost to cervical cancer each year.

A friendly reminder to kick off your week. 💡

Jan 12

Open

A friendly reminder to kick off your week. 💡

2025 felt like an impossible year for global health. Funding disappeared, measles and other diseases surged, and longstanding multilateral partnerships changed overnight.

We`ve learned that progress isn`t permanent. But it also hasn`t stopped.

For what defined the year and what lies ahead, see our latest blog #linkinbio.

Jan 9

Open

2025 felt like an impossible year for global health. Funding disappeared, measles and other diseases surged, and longstanding multilateral partnerships changed overnight.

We've learned that progress isn't permanent. But it also hasn't stopped.

For what defined the year and what lies ahead, see our latest blog #linkinbio.

In 2026, vaccines could make the impossible, possible.

It`s been 100 years since the world has seen a new TB vaccine, yet right now, tens of thousands of volunteers are testing one that could rewrite that story.

Meanwhile, Brazil is rolling out an equally remarkable single-dose dengue vaccine, a critical development as climate change pushed cases past 14 million globally in 2024.

And in Sub-Saharan Africa’s “meningitis belt,” a $3 vaccine is quietly ending a century of recurring outbreaks is protecting against 5 strains of the disease at a price communities can afford.

These aren’t distant possibilities, but close realities. Stay tuned tomorrow to learn more.

Jan 7

Open

In 2026, vaccines could make the impossible, possible.

It's been 100 years since the world has seen a new TB vaccine, yet right now, tens of thousands of volunteers are testing one that could rewrite that story.

Meanwhile, Brazil is rolling out an equally remarkable single-dose dengue vaccine, a critical development as climate change pushed cases past 14 million globally in 2024.

And in Sub-Saharan Africa’s “meningitis belt,” a $3 vaccine is quietly ending a century of recurring outbreaks is protecting against 5 strains of the disease at a price communities can afford.

These aren’t distant possibilities, but close realities. Stay tuned tomorrow to learn more.

As we near the end of 2025, we celebrate another year of working towards #HealthForAll.

Thank you for all of your hard work to ensure that everyone, everywhere, gets a shot at a healthy life. Happy holidays from the Shot@Life team—we`ll see you in the new year! 💚

Dec 19

Open

As we near the end of 2025, we celebrate another year of working towards #HealthForAll.

Thank you for all of your hard work to ensure that everyone, everywhere, gets a shot at a healthy life. Happy holidays from the Shot@Life team—we'll see you in the new year! 💚

The facts are simple: vaccines work. But the reality? Far more complicated.

2025 showed the uncomfortable truth that vaccine breakthroughs aren’t the same as getting them into arms. We watched malaria vaccines roll out across countless new countries while measles cases climbed 34-fold in the Americas.

The bottleneck isn’t science. It’s systems. It’s reaching the last mile, it’s maintaining coverage when funding plateaus or conflicts disrupt supply chains, and it’s instilling trust at the community level.

Keep swiping to see where we stand in the fight against three key diseases this year.

Dec 17

Open